IL116742A0 - Pharmaceutical composition comprising a growth hormone - Google Patents

Pharmaceutical composition comprising a growth hormone

Info

Publication number
IL116742A0
IL116742A0 IL11674296A IL11674296A IL116742A0 IL 116742 A0 IL116742 A0 IL 116742A0 IL 11674296 A IL11674296 A IL 11674296A IL 11674296 A IL11674296 A IL 11674296A IL 116742 A0 IL116742 A0 IL 116742A0
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
growth hormone
hormone
growth
pharmaceutical
Prior art date
Application number
IL11674296A
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL116742A0 publication Critical patent/IL116742A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
IL11674296A 1995-01-13 1996-01-12 Pharmaceutical composition comprising a growth hormone IL116742A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37226895A 1995-01-13 1995-01-13
US45580895A 1995-05-31 1995-05-31

Publications (1)

Publication Number Publication Date
IL116742A0 true IL116742A0 (en) 1996-05-14

Family

ID=27005704

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11674296A IL116742A0 (en) 1995-01-13 1996-01-12 Pharmaceutical composition comprising a growth hormone

Country Status (6)

Country Link
EP (1) EP0805689A1 (en)
JP (1) JPH10511964A (en)
KR (1) KR19980701351A (en)
AU (1) AU4329596A (en)
IL (1) IL116742A0 (en)
WO (1) WO1996021460A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA965367B (en) * 1995-07-12 1997-01-23 Novo Nordisk As A pharmaceutical formulation
CA2230448A1 (en) * 1995-08-28 1997-03-06 Showa Yakuhin Kako Co., Ltd. Composition for local anesthesia
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
EP1309312A2 (en) 2000-08-07 2003-05-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
DK1581251T3 (en) 2002-12-31 2016-06-27 Althea Tech Inc CRYSTALS OF HUMAN GROWTH HORMON AND METHODS OF PRODUCING THEREOF
EP2501367B1 (en) * 2009-11-17 2015-01-21 Ipsen Pharma S.A.S. Formulation for HGH and RHIGF-1 combination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
CA2125855C (en) * 1991-12-20 2008-05-13 Hans Holmegaard Sorensen A stabilized pharmaceutical formulation comprising growth hormone and histidine
DK204791D0 (en) * 1991-12-20 1991-12-20 Novo Nordisk As UNKNOWN PHARMACEUTICAL PREPARATION

Also Published As

Publication number Publication date
WO1996021460A1 (en) 1996-07-18
EP0805689A1 (en) 1997-11-12
KR19980701351A (en) 1998-05-15
JPH10511964A (en) 1998-11-17
AU4329596A (en) 1996-07-31

Similar Documents

Publication Publication Date Title
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
ZA965368B (en) A pharmaceutical formulation
HUP9903536A3 (en) Pharmaceutical composition stabilized with a basic agent
HU9601698D0 (en) Pharmaceutical composition
AU1868595A (en) Human growth hormone
ZA958606B (en) A pharmaceutical formulation
ZA962214B (en) Pharmaceutical composition
GB9519667D0 (en) Pharmaceutical composition
IL112639A0 (en) A pharmaceutical composition containing pravastin
ZA963590B (en) Pharmaceutical composition
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone
ZA9610426B (en) Pharmaceutical composition
GB9502695D0 (en) Pharmaceutical composition
IL116741A0 (en) Pharmaceutical composition comprising a growth hormone
ZA964372B (en) A pharmaceutical formulation
IL122519A0 (en) Stabilized pharmaceutical compositions comprising a growth hormone and a peptide
NZ268125A (en) Growth hormone pharmaceutical composition
AU4333796A (en) A nutritive composition containing milt
HU9602822D0 (en) Pharmaceutical composition
ZA963388B (en) A pharmaceutical composition
HUP9602732A3 (en) Pharmaceutical composition comprising lanperisone
ZA95736B (en) Pharmaceutical composition
GB9425757D0 (en) A pharmaceutical composition
ZA967973B (en) Human growth hormone variants
IL114077A0 (en) Pharmaceutical compositions comprising a cytokine